Table 3.
Magnetic susceptibility values of significant regions of interest among participants
| Regions | HC (n = 32) | PD-RBD- (n = 24) | PD-RBD+ (n = 27) | p-value | p-value (post hoc) | ||
|---|---|---|---|---|---|---|---|
| HC vs PD-RBD- | HC vs PD-RBD+ | PD-RBD- vs PD-RBD+ | |||||
| QSM (ppb) | |||||||
| right SNpc | 65.16 ± 18.46 | 76.71 ± 18.04 | 78.93 ± 21.35 | 0.016* | 0.03* | 0.008** | 0.683 |
| left SNpc | 61.38 ± 15.89 | 72.07 ± 16.79 | 73.68 ± 22.30 | 0.024* | 0.035* | 0.013* | 0.757 |
| χpara (ppb) | |||||||
| right SNpc | 77.46 ± 19.79 | 93.06 ± 22.07 | 96.03 ± 25.81 | 0.004** | 0.012* | 0.002** | 0.64 |
| left SNpc | 75.07 ± 18.12 | 86.93 ± 21.14 | 91.58 ± 25.96 | 0.014* | 0.047* | 0.005** | 0.449 |
*p < 0.05, **p < 0.01; QSM quantitative susceptibility mapping (value), χpara paramagnetic susceptibility mapping (value), ppb parts per billion, SNpc substantia nigra pars compacta, PD-RBD- Parkinson’s disease without rapid eye movement sleep behavior disorder, PD-RBD+ Parkinson’s disease with secondary rapid eye movement sleep behavior disorder.